Introduction Today, GLP-1 drugs are most commonly used for diabetes and weight loss, but there is potential for GLP-1 therapies to transform healthcare by offering new solutions for managing chronic conditions
Myo-inositol + D-chiro-inositol (2,050mg total in a 40:1 ratio): Research suggests that individuals with PCOS may experience disruptions in the balance between myo-inositol (MI) and D-chiro-inositol (DCI) two biologically active forms of inositol particularly in the ovaries
American rugby player Ilona Maher was one of Team USAs breakout stars of the 2024 Paris Olympics and with the 2028 summer games coming to Los Angeles, Maher is contemplating whether she wants to compete
Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a key therapeutic class in the management of T2D and obesity, where they not only improve glycemic control and promote weight loss, but also exert significant effects on the gastrointestinal system
A loose tooth if the cancer involves the underlying bone
Lysine appears to have an invaluable role and wound healing Studies have only looked at oral lysine supplements on wound healing in animals, so more studies in humans are needed